The global burden of Plasmodium vivax malaria is obscure and insidious

The global burden of Plasmodium vivax malaria is obscure and insidious

Estimates of the global burdens of morbidity attributable to acute attacks of Plasmodium falciparum malaria typically dwarf those of Plasmodium vivax, i.e., hundreds of millions versus tens of millions of cases.<br><br> Global burden estimates take no account of latent and subpatent rese...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Battle, KE, Baird, JK
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science 2021

Míreanna comhchosúla

The burden of Plasmodium vivax malaria
de réir: Battle, K
Foilsithe / Cruthaithe: (2015)

Neglect of Plasmodium vivax malaria.
de réir: Baird, J
Foilsithe / Cruthaithe: (2007)

Global epidemiology of Plasmodium vivax
de réir: Howes, R, et al.
Foilsithe / Cruthaithe: (2016)

Global Epidemiology of Plasmodium vivax
de réir: Howes, R, et al.
Foilsithe / Cruthaithe: (2016)

Diagnosis and treatment of Plasmodium vivax malaria.
de réir: Baird, K, et al.
Foilsithe / Cruthaithe: (2012)

Diagnosis and treatment of Plasmodium vivax malaria
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (2016)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
de réir: Twohig, K, et al.
Foilsithe / Cruthaithe: (2019)

Challenges in the Control and Elimination of Plasmodium vivax Malaria
de réir: Asih, P, et al.
Foilsithe / Cruthaithe: (2018)

The global public health significance of Plasmodium vivax.
de réir: Battle, K, et al.
Foilsithe / Cruthaithe: (2012)

Evidence and implications of mortality associated with acute Plasmodium vivax malaria.
de réir: Baird, J
Foilsithe / Cruthaithe: (2013)

“Lively” invasive Plasmodium vivax causes severe and complicated malaria
de réir: Baird, J
Foilsithe / Cruthaithe: (2019)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
de réir: Baird, J
Foilsithe / Cruthaithe: (2018)

Plasmodium vivax Malaria
de réir: Dhanpat K. Kochar, et al.
Foilsithe / Cruthaithe: (2005-01-01)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
de réir: Katherine A Twohig, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Global economic costs due to Plasmodium Vivax malaria treatment and the cost-benefit of radical cure
de réir: Devine, A, et al.
Foilsithe / Cruthaithe: (2018)

Plasmodium vivax malaria endemicity in Indonesia in 2010
de réir: Elyazar, I, et al.
Foilsithe / Cruthaithe: (2012)

The effects of urbanization on global Plasmodium vivax malaria transmission.
de réir: Qi, Q, et al.
Foilsithe / Cruthaithe: (2012)

The effects of urbanization on global <it>Plasmodium vivax</it> malaria transmission
de réir: Qi Qiuyin, et al.
Foilsithe / Cruthaithe: (2012-12-01)

Attacking Plasmodium vivax
de réir: Baird, J
Foilsithe / Cruthaithe: (2016)

The anaemia of Plasmodium vivax malaria.
de réir: Douglas, N, et al.
Foilsithe / Cruthaithe: (2012)

The anaemia of <it>Plasmodium vivax</it> malaria
de réir: Douglas Nicholas M, et al.
Foilsithe / Cruthaithe: (2012-04-01)

Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
de réir: Wells, T, et al.
Foilsithe / Cruthaithe: (2010)

Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
de réir: Maguire, J, et al.
Foilsithe / Cruthaithe: (2006)

Acquired immunity in a holoendemic setting of Plasmodium falciparum and p. Vivax malaria.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (2007)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (2018)

Chloroquine resistance in Plasmodium vivax.
de réir: Baird, J
Foilsithe / Cruthaithe: (2004)

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria
de réir: Baird, J
Foilsithe / Cruthaithe: (2013)

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.
de réir: Baird, J
Foilsithe / Cruthaithe: (2013)

THE HUMAN LIVER AS A RESERVOIR OF INFECTION: THE EPIDEMIOLOGY AND CONTROL OF MALARIA CAUSED BY PLASMODIUM VIVAX
de réir: Baird, J
Foilsithe / Cruthaithe: (2013)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
de réir: Gething, P, et al.
Foilsithe / Cruthaithe: (2012)

The prevention and treatment of Plasmodium vivax malaria
de réir: Chu, CS, et al.
Foilsithe / Cruthaithe: (2021)

Effects of Plasmodium vivax malaria in pregnancy.
de réir: Nosten, F, et al.
Foilsithe / Cruthaithe: (1999)

Management of relapsing Plasmodium vivax malaria
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2016)

The role of cytokines in Plasmodium vivax malaria
de réir: K. N. Mendis, et al.
Foilsithe / Cruthaithe: (1992-01-01)

Severe Plasmodium vivax Malaria in Pakistan
de réir: Ali Bin Sarwar Zubairi, et al.
Foilsithe / Cruthaithe: (2013-11-01)

Neutrophil paralysis in Plasmodium vivax malaria.
de réir: Fabiana Maria de Souza Leoratti, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Changing profile of Plasmodium vivax malaria
de réir: M.E. Yeolekar, et al.
Foilsithe / Cruthaithe: (2014-04-01)

The prevention and treatment of Plasmodium vivax malaria.
de réir: Cindy S Chu, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Geographical variation in Plasmodium vivax relapse
de réir: Battle, K, et al.
Foilsithe / Cruthaithe: (2014)

Geographical variation in Plasmodium vivax relapse.
de réir: Battle, K, et al.
Foilsithe / Cruthaithe: (2014)